Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53

Despite considerable progress, the treatment of acute leukemia continues to be a challenge for a significant majority of patients. Using a well-characterized preclinical mouse model of acute promyelocytic leukemia (APL), we evaluated here the antileukemic efficacy of RT53, an anticancer peptide with...

Descripción completa

Detalles Bibliográficos
Autores principales: Habault, Justine, Kaci, Anna, Pasquereau-Kotula, Ewa, Fraser, Claire, Chomienne, Christine, Dombret, Hervé, Braun, Thorsten, Pla, Marika, Poyet, Jean-Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051191/
https://www.ncbi.nlm.nih.gov/pubmed/32158621
http://dx.doi.org/10.1080/2162402X.2020.1728871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051191/
https://www.ncbi.nlm.nih.gov/pubmed/32158621
http://dx.doi.org/10.1080/2162402X.2020.1728871

Ejemplares similares